北美与国际实验室宫颈细胞学-组织学对照实践现状:CAP细胞病理委员会调查结果
美国病理学家协会(CAP)细胞病理委员会通过问卷调查评估全球宫颈细胞学-组织学对照(CHC)的实施现状。结果显示CHC实践几乎全球普及,总体实施率为87.0%(568/653),CHC材料可及性高,常在对应外科病理 review 时实时进行;不一致原因调查方式在北美与国际实验室间存在差异,不一致原因主要为采样问题。
要点
- CHC全球实施率87.0%(568/653),材料可及性高,常实时/同步进行。
- 北美实验室通常由单一病理医师复核所有不一致的细胞与组织切片,国际实验室则由第二病理医师复核组织切片。
- CHC不一致原因以采样问题为主;常用统计指标包括与后续活检符合率、细胞技师筛查错误率及判读错误率。
核心结论
- CHC实践在全球范围内几乎普遍采用,总体实施率为87.0%(568/653)。
- 北美与国际实验室在CHC的实施地点、病例识别、可及性、执行时机、不一致调查者及不一致类型等方面存在可识别的差异。
- CHC不一致的主要原因以采样问题为主。
研究设计与样本
- 由CAP细胞病理委员会设计问卷,分发至CAP妇科细胞病理PAP教育项目邮寄名单的参与者。
- 对调查数据进行分析,共纳入653份回复,其中568份(87.0%)实施CHC。
主要发现
- CHC材料可及性高,常在对应外科病理review时实时/同步进行。
- 北美实验室通常由单一病理医师复核所有不一致的组织学与细胞学切片以确定不一致原因。
- 国际实验室则由第二病理医师复核组织学切片以确定不一致原因。
- CHC不一致原因主要为采样问题。
- 常用统计指标包括与后续活检符合的总病例百分比、细胞技师筛查错误率及细胞技师判读错误率。
关键数值与推荐
- CHC总体实施率为87.0%(568/653)。
- 常用监测指标:与后续活检符合的总病例百分比、细胞技师筛查错误率、细胞技师判读错误率。
临床怎么用
- 实验室可参照CAP细胞病理检查清单实施并优化CHC流程。
- 应关注CHC材料可及性、实时/同步对照及不一致病例的调查方式。
- 可选用与后续活检符合率、筛查错误率及判读错误率等指标监测CHC质量。
局限性
- 调查基于CAP妇科细胞病理PAP教育项目邮寄名单的参与者,可能存在选择偏倚。
- 调查结果反映自报实践,未与现场核查数据验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT.—: The College of American Pathologists (CAP) updated the Laboratory Accreditation Program Cytopathology Checklist to assist laboratories in meeting and exceeding the Clinical Laboratory Improvement Amendments standards for gynecologic cytologic-histologic correlation (CHC). OBJECTIVE.—: To survey the current CHC practices. DESIGN.—: Data were analyzed from a survey developed by the committee and distributed to participants in the CAP Gynecologic Cytopathology PAP Education Program mailing. RESULTS.—: Worldwide, CHC practice is nearly universally adopted, with an overall rate of 87.0% (568 of 653). CHC material was highly accessible. CHC was commonly performed real time/concurrently at the time the corresponding surgical pathology was reviewed. Investigation of CHC discordances varied with North American laboratories usually having a single pathologist review all discrepant histology and cytology slides to determine the reason for discordance, while international laboratories have a second pathologist review histology slides to determine the reason for discordance. The cause of CHC discordance was primarily sampling issues. The more common statistical metrics for CHC monitoring were the total percentage of cases that correlated with subsequent biopsies, screening error rate by cytotechnologist, and interpretative error rate by cytotechnologist. CONCLUSIONS.—: Many laboratories have adopted and implemented the CHC guidelines with identifiable differences in practices between North American and international laboratories. We identify the commonalities and differences between North American and international institutional practices including where CHC is performed, how CHC cases are identified and their accessibility, when CHC is performed, who investigates discordances, what discordances are identified, and how the findings affect quality improvement.
引用
- Nguyen LN, Crothers BA, Davey DD, et al. Current State of Cytologic-Histologic Correlation Implementation for North American and International Laboratories: Results of the College of American Pathologists Cytopathology Committee Laboratory Practices in Gynecologic Cytology Survey. Arch Pathol Lab Med. 2023. PMID: 35271691. doi:10.5858/arpa.2021-0223-CP
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。